| Literature DB >> 35956472 |
Pattralak Songserm1,2, Poramaporn Klanrit3, Poramate Klanrit4,5, Jutarop Phetcharaburanin4,5, Pornthap Thanonkeo2,6, Jirawan Apiraksakorn2,6, Khamphee Phomphrai7, Preekamol Klanrit2,5,6.
Abstract
The potential benefits of natural plant extracts have received attention in recent years, encouraging the development of natural products that effectively treat various diseases. This is the first report on establishing callus and cell suspension cultures of Rhinacanthus nasutus (L.) Kurz. A yellow friable callus was successfully induced from in vitro leaf explants on Murashige and Skoog medium supplemented with 1 mg/L 2,4-dichlorophenoxyacetic acid and 1 mg/L 1-naphthalene acetic acid. A selected friable callus line was used to establish the cell suspension culture with the same medium. The antioxidant assays showed that the leaf- and ethanolic-suspension-cultured cell (SCC) extracts exhibited high antioxidant potential. In addition, the in vitro cytotoxicity revealed by the MTT assay demonstrated potent antiproliferative effects against the oral cancer cell lines ORL-48 and ORL-136 in a dose-dependent manner. Several groups of compounds, including terpenoids, phenolics, flavonoids, quinones, and stilbenes, were identified by UHPLC-QToF-MS, with the same compounds detected in leaf and SCC extracts, including austroinulin, lucidenic acid, esculetin, embelin, and quercetin 3-(2″-p-hydroxybenzoyl-4″-p-coumarylrhamnoside). The present study suggests the value of further investigations for phytochemical production using R. nasutus cell suspension culture.Entities:
Keywords: Rhinacanthus nasutus; anticancer; antioxidant; callus; cell suspension culture
Year: 2022 PMID: 35956472 PMCID: PMC9370634 DOI: 10.3390/plants11151994
Source DB: PubMed Journal: Plants (Basel) ISSN: 2223-7747
Figure 1Rhinacanthus nasutus (L.) Kurz—A Thai medicinal plant used in the present study: (A) a mature plant, (B) a shoot tip, and (C) a flower.
The effects of different combinations of plant growth regulators on callus induction in R. nasutus.
| 2,4-D (mg/L) | NAA (mg/L) | % Callus Induction * | Callus Response |
|---|---|---|---|
| 0 | 0 | 0 c | no growth response |
| 0.50 | 1.00 | 100.00 ± 0.00 a | friable, yellow |
| 1.00 | 1.00 | 100.00 ± 0.00 a | friable, yellow |
| 1.50 | 1.00 | 100.00 ± 0.00 a | friable, yellow |
| 2.00 | 1.00 | 100.00 ± 0.00 a | friable, yellow |
| 0.00 | 1.00 | 26.67 ± 0.58 b | compact, yellow |
| 0.00 | 2.00 | 0 c | no growth response |
| 0.50 | 2.00 | 33.33 ± 0.58 b | compact, yellow |
| 1.00 | 2.00 | 33.33 ± 0.58 b | compact, yellow |
| 1.50 | 2.00 | 26.67 ± 0.58 b | compact, yellow |
| 2.00 | 2.00 | 26.67 ± 0.58 b | compact, yellow |
| 1.00 | 0.00 | 0 c | no growth response |
| 2.00 | 0.00 | 0 c | no growth response |
* The data are presented as the means ± standard deviation (SD) from three independent experiments. Mean values in the column followed by different superscripts (a, b or c) are significantly different according to the analysis of variance (ANOVA) with Duncan’s multiple range test (DMRT) at the level of 0.05 (p ≤ 0.05).
Figure 2Callus culture of R. nasutus: (A) callus initiation from leaf explants after 3 weeks; (B) callus growth on CIM (MS medium supplemented with 1 mg/L 2,4-D and 1 mg/L NAA) after culturing for 7 days; (C) callus proliferation on CIM after 15 days of culture.
Figure 3Establishment of R. nasutus cell suspension culture: (A) leaf-derived yellow friable callus; (B) SCCs of R. nasutus; (C) morphology of 15 day friable callus under a bright-field microscope. The scale bar represents 25 µm.
Figure 4Growth profile of R. nasutus cell suspension cultures during 30 days of culture in liquid CIM.
Figure 5Antioxidant capacity of the ethanolic leaf and SCC extracts of R. nasutus (A) as determined by FRAP assay and (B) by DPPH and ABTS assays. The data are presented as the means ± SD of the results of triplicate determinations. Bars with different letters are significantly different according to an independent-samples t test at p ≤ 0.05.
Figure 6Oral cancer cell viability after treatment with ethanolic leaf and SCC extracts of R. nasutus: (A) ORL-48 cell line and (B) ORL-136 cell line. The data are presented as the means ± SD of the results of triplicate determinations. Bars with different letters at each concentration are significantly different according to an independent-samples t test at p ≤ 0.05.
A list of metabolites in R. nasutus leaf extract.
| Proposed | Class * | Subclass * | Retention Time (min) | Product Ions (m/z) | Mass | Molecular | Remarks |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Austroinulin | Prenol lipids | Diterpenoids | 43.58 | 345.24 | 322.25 | C20 H34 O3 | Found in |
| Inulicin | Prenol lipids | Terpene lactones | 26.71 | 307.16 | 308.16 | C17 H24 O5 | May suppress angiogenesis and lung cancer cell growth [ |
| Lucidenic acid | Prenol lipids | Sesquiterpenoids | 41.91 | 481.26 | 458.27 | C27 H38 O6 | Lucidenic acid A, B, N caused cell cycle arrest in G1 phase/inhibited PMA-induced HCC invasion and apoptosis in human leukaemia cells HL-60 [ |
| Corosolic acid | Prenol lipids | Triterpenoids | 43.30 | 495.35 | 472.36 | C30 H48 O4 | Inhibits human colorectal cancer cells [ |
| Ganoderic acid | Prenol lipids | Triterpenoids | 40.42 | 555.29 | 532.31 | C30 H44 O8 | Inhibits cell proliferation, viability, and ROS and mRNA expression of TNF [ |
| Punctaporin B | Prenol lipids | - | 41.32 | 251.17 | 252.17 | C15 H24 O3 | Found in |
|
| |||||||
| (E)-2-glucosyl-3,4′,5 trihydroxy stilbene | Stilbenes | Stilbene glycosides | 27.74 | 413.12 | 390.13 | C20 H22 O8 | Complementary and alternative medicine for cancer therapy [ |
| Ferulic acid | Cinnamic acids and derivatives | Hydroxycinnamic acids and derivatives | 16.07 | 193.05 | 194.06 | C10 H10 O4 | Able to suppress tumors in breast cancer, cervical carcinoma cells, prostate cancer cells, and pancreatic cancer cells [ |
| Trans-cinnamic acid | Cinnamic acids and derivatives | Cinnamic acids | 33.20 | 149.06 | 148.05 | C9 H8 O2 | Some inhibitory activity against enzymes from the human liver and the human cholangiocarcinoma cell line [ |
| 4-hydroxy coumarin | Coumarins and derivatives | Hydroxycoumarins | 28.54 | 163.04 | 162.03 | C9 H6 O3 | Inhibits cell proliferation in the gastric carcinoma cell line [ |
| Esculetin | Coumarins and derivatives | Hydroxycoumarins | 13.12 | 177.02 | 178.03 | C9 H6 O4 | Inhibits migration and invasion of laryngeal cancer [ |
|
| |||||||
| Embelin | Prenol lipids | Quinone and hydroquinone lipids | 27.41 | 293.18 | 294.19 | C17 H26 O4 | Inhibits TNF-α and cancer cell metastasis [ |
| Isoplumbagin | Naphthalenes | Naphthoquinones | 23.39 | 187.04 | 188.05 | C11 H8 O3 | Suppresses oral, lung, prostate, and cervical cancer cells [ |
| 1,3,5,8-tetra hydroxy -6-methoxy-2-methyl anthraquinone | Others | Anthraquinones | 28.85 | 334.09 | 316.06 | C16 H12 O7 | Inhibits cancer progression by kinases, topoisomerases, telomerases, matrix metallo proteinases, and G-quadruplexes [ |
|
| |||||||
| 2′,4′-dihydroxy-7-methoxy-8-prenylflavan | Flavonoids | Flavans | 26.69 | 363.16 | 340.17 | C21 H24 O4 | Also found in |
| Rutin | Flavonoids | Flavonoid glycosides | 14.92 | 609.15 | 610.15 | C27 H30 O16 | Anticancer effects on human cervical cancer cells [ |
| Vitexin 4′-O-galactoside | Flavonoids | Flavonoid glycosides | 15.52 | 593.15 | 594.16 | C27 H30 O15 | Many flavonoids have been isolated from and identified in flowers of the genus |
| Quercetin 3-(2′′-p-hydroxybenzoyl-4′′-p-coumaryl rhamnoside) | Flavonoids | Flavones | 43.83 | 715.17 | 714.16 | C37 H30 O15 | Quercetin suppresses cyclooxygenase-2 (COX-2) expression in human breast cancer cells [ |
* Class and subclass were assigned according to the Human Metabolome Database (HMDB) (https://hmdb.ca) (accessed on 9 May 2022).
A list of metabolites in R. nasutus SCC extract.
| Proposed | Class * | Subclass * | Retention Time (min) | Product Ions (m/z) | Mass | Molecular | Remarks |
|---|---|---|---|---|---|---|---|
|
| |||||||
| Austroinulin | Prenol lipids | Diterpenoids | 43.10 | 345.24 | 322.25 | C20 H34 O3 | Found in |
| Lucidenic acid | Prenol lipids | Sesquiterpenoids | 38.46 | 463.31 | 462.30 | C27 H42 O6 | Lucidenic acid A, B, N caused cell cycle arrest in G1 phase/inhibited PMA-induced HCC invasion and apoptosis in human leukaemia cells HL-60 [ |
| Camelledionol | Prenol lipids | Triterpenoids | 41.48 | 441.34 | 440.33 | C29 H44 O3 | Inhibits the A549, LLC, HL-60, and MCF-7 cancer cell lines [ |
|
| |||||||
| Pterostilbene glycinate | Stilbenes | - | 18.38 | 336.12 | 313.13 | C18 H19 N O4 | Effective in treat ment of melanoma and has anticancer activity [ |
| Esculetin | Coumarins and derivatives | Hydroxycoumarins | 13.08 | 177.02 | 178.03 | C9 H6 O4 | Inhibits migration and invasion of laryngeal cancer [ |
| N-feruloyltyramine | Cinnamic acids and derivatives | Hydroxycinnamic acids and derivatives | 19.03 | 312.12 | 313.13 | C18 H19 N O4 | Significantly fights against the oxidative damage induced by H2O2 and inhibits HepG2 cells [ |
|
| |||||||
| Embelin | Prenol lipids | Quinone and hydroquinone lipids | 27.50 | 293.18 | 294.19 | C17 H26 O4 | Inhibits TNF-α and cancer cell metastasis [ |
| 1,4-naphtho quinone | Naphthalenes | Naphthoquinones | 14.04 | 159.04 | 158.04 | C10 H6 O2 | Its derivatives demonstrate good anticancer, antioxidant, antimicrobial, and anti-inflammatory effects [ |
|
| |||||||
| Hesperetin | Flavonoids | o-methylated flavonoids | 20.359 | 301.07 | 302.08 | C16 H14 O6 | A drug used for lowering cholesterol and treating multiple cancers [ |
| Quercetin 3-(2″-p-hydroxybenzoyl | Flavonoids | Flavones | 43.83 | 715.17 | 714.16 | C37 H30 O15 | Quercetin suppresses cyclooxygenase-2 (COX-2) expression in human breast cancer cells [ |
* Class and subclass were assigned according to the Human Metabolome Database (HMDB) (https://hmdb.ca) (accessed on 9 May 2022).